STOCK TITAN

Mirum Pharmaceuticals Inc - MIRM STOCK NEWS

Welcome to our dedicated news page for Mirum Pharmaceuticals (Ticker: MIRM), a resource for investors and traders seeking the latest updates and insights on Mirum Pharmaceuticals.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Mirum Pharmaceuticals's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Mirum Pharmaceuticals's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.44%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.92%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.92%
Tags
earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.12%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.17%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.96%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.35%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.01%
Tags
earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.81%
Tags
earnings
Mirum Pharmaceuticals Inc

Nasdaq:MIRM

MIRM Rankings

MIRM Stock Data

1.18B
35.19M
2.25%
111.96%
17.31%
Research and Development in Biotechnology
Professional, Scientific, and Technical Services
Link
United States
Foster City

About MIRM

mirum pharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. its lead product candidate is maralixibat, an investigational oral drug that is in phase 3 clinical trial for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of alagille syndrome and biliary atresia disease. the company is also develops volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. mirum pharmaceuticals, inc. was founded in 2018 and is headquartered in foster city, california.